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Abstract: In adults, migraine with aura is considered to be a risk factor for stroke, especially when other risk factors exist. 
However, the relationship between migraine with aura and risk of cerebral infarct in children has not been well established 
and requires further study. We describe four young patients who suffered from migraine with aura and focal neurological 
deficits. All four patients had migraine with aura and focal neurological deficits associated with headaches. Two of the 
four young patients had cerebral infarct during their migraine headaches. Detailed investigation did not reveal the etiology 
of the cerebral infarct in these two adolescents. No risk factor for stroke was apparent in any of the four patients and no 
specific risk factor or reliable clinical feature could be used to identify these young patients at risk for irreversible cerebral 
ischemia. Thus, our observations provide support that there may be an association between migraine with aura and risk of 
stroke in children. We, therefore, advocate aggressive treatment using prophylactic agents to prevent migraine attacks in 
children suffering from migraine with aura, especially when auras are prolonged. 
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INTRODUCTION 
  According to the International Headache Society, mi-
graine may be classified into a number of categories among 
which are migraine with aura and migrainous infarct [1]. 
Auras include focal neurological deficits such as reversible 
visual disturbances, sensory symptoms, and/or dysphasic 
speech. In addition, hemiplegic symptoms are considered to 
be a migraine aura, though migraine with hemiplegia may be 
coded separately [1]. In any case, when making a diagnosis 
of migraine with aura, it is important to note that the head-
ache itself may occur simultaneously with or follow the aura 
and that the neurological deficits usually resolve within 60 
minutes and only rarely persist longer than 24 hours [1]. 
  In contrast to migraine with aura, permanent neurological 
sequelae associated with attacks of migraine were described 
by Charcot as early as the 19
th century and were originally 
referred to as complicated migraine [2]. This form of mi-
graine, now termed migrainous infarct, accounts for between 
0.5 and 1.5% of all strokes [3]. The prevalence of active mi-
graine during acute ischemic stroke in the Lusanne stroke 
registry was reported to be as high as 3.7% for all patients, 
15.8% for patients under the age of 45, and 74% for women 
under 45 years of age [4]. In addition, Henrich and Horwitz 
reported a migraine prevalence of 19% in patients with 
ischemic stroke under the age of 65 [5]. Furthermore, it has 
been suggested that migraine with aura is a risk factor for 
ischemic stroke [6-9]
 with approximately a 2-fold increased  
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risk in women having migraine with aura as compared to 
women with no history of migraine [10].
 An increased fre-
quency of white matter hyper-intensities seen on magnetic 
resonance imaging (MRI) of the brain have also been re-
ported in patients with migraine, an observation consistent 
with a history of frequent ischemia [11,12]. A recent study 
showed an apparent association between migraine frequency 
and cardiovascular disease including ischemic stroke in 
women suffering from migraine with aura. Ischemic stroke 
was associated with high frequency (weekly) migraine at-
tacks [13]. Taken together, these studies show a significant 
association between migraine with aura and ischemic stroke, 
especially in younger patients and in women.  
  The diagnosis of migraine in children and adolescents is 
more complex than in adults primarily because they often 
lack typical features. In general, migraine with aura is 
thought to be less prevalent in children with migrainous in-
farct even less commonly observed [14]. A number of epi-
demiological studies evaluating the risk of ischemic stroke in 
migraineurs included adolescents in their study populations 
[5,15-22].
  These studies demonstrated that migraine with 
aura was indeed a risk factor for ischemic stroke, especially 
in the presence of other stroke risk factors including contra-
ceptive use, hypertension, and diabetes. However, these epi-
demiological studies on risk factors for migrainous stroke 
included predominantly adult subjects, with only a small 
number of adolescent participants. Currently, little is known 
about the risk of migrainous stroke in populations consisting 
exclusively of children and adolescents.  
  While it is clear that migraine with aura is a risk factor 
for stroke in adults, such a relationship has not been ade-
quately established in children. In this case series review, we 112     The Open Neurology Journal, 2010, Volume 4  Ming et al. 
present the clinical characteristics of four adolescents who 
exhibited migraine with focal neurological deficits, with or 
without radiographic ischemic infarcts, along with a brief 
review and discussion on the pathogenesis of migrainous 
infarction. With these observations, we suggest prophylactic 
migraine treatment for children suffering from migraine with 
aura. 
  This study was approved by the Institutional Review 
Board of our institute and informed consent procedure was 
not applicable to this retrospective review without personal 
identifiers.  
RESULTS 
Case 1 
  A 16 year-old non-obese Hispanic girl with approxi-
mately a seven-week history of migraine headache presented 
to our emergency department in the early summer of 2000 
with a sudden onset of left hemiparesis. Her previous mi-
graine episodes were accompanied by nausea and photopho-
bia but were neither associated with aura nor complicated by 
neurological deficits. There was no family history of mi-
graine or stroke. She did not smoke and had never used oral 
contraceptives, hormonal treatment or illicit drugs. She had 
been otherwise healthy. Earlier on the day of presentation, 
the patient experienced an aura of tingling in her left hand 
that rapidly progressed to involve her left face and leg. The 
patient subsequently developed a complete left hemiplegia. 
One hour after the onset of symptoms, the patient was found 
to also have a complete left hemisensory loss. Her symptoms 
resolved completely as she was undergoing a head computed 
tomography (CT) scan and CT angiography, both of which 
were normal. There was no evidence of cerebral vasculopa-
thy. Following the CT angiography the patient developed 
another episode of transient left hemiplegia that rapidly im-
proved but left a residual mild pronator drift. Fluid-
attenuated inversion recovery MRI of the brain was per-
formed two and a half hours after onset of her initial symp-
toms and revealed increased signal intensity in the right ba-
sal ganglia extending into the posterior limb of the right in-
ternal capsule, most consistent with an acute ischemic infarct 
(Fig. 1). Diffusion-weight MRI and apparent diffusion coef-
ficient confirmed the presence of an ischemic infarct (images 
not shown). The patient was started on intravenous heparin 
to maintain a partial thromboplastin time of 60-80 seconds. 
Evaluation for a possible coagulopathy prior to initiation of 
heparin, inborn error of metabolism and mitochondrial dis-
orders was unremarkable. A trans-esophageal echocardio-
gram revealed no evidence of a patent foramen ovale, 
thrombus, or other structural abnormality. Approximately six 
hours after the onset of hemiplegia, the patient developed a 
right temporal pulsatile headache associated with left arm 
tingling which rapidly resolved. Migrainous infarction was 
considered and the possibility of vasospasm responsible for 
the reversible sensory deficit was raised. The patient was 
started on nimodipine 30mg via parental route every 6 hours 
for 48 hours followed by verapamil 80 mg daily for pre-
sumed cerebral vasospasm. The doses of nimodipine and 
verapamil were carefully titrated to avoid hypotension. By 
the following day, her headache and left pronator drift had 
resolved completely. After her discharge, the patient contin-
ued to have episodic headaches with left arm numbness that 
were often triggered by salty and greasy food. The diagnosis 
of migraine with aura was thus made. The verapamil dose 
was increased to 120 mg daily and the patient was advised to 
refrain from any offensive food. In addition, valproic acid 
was added to the patient’s migraine prophylaxis regimen and 
she has remained headache free and has no additional neuro-
logical deficits for at least four years of follow-up.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Fluid-attenuated inversion recovery (FLAIR) MRI showed 
a hyper-intensity signal in the right basal ganglia extending to the 
posterior limb of the right internal capsule. 
 
Case 2 
  A 12 year-old thin Filipino boy with a prior history of 
migraine headache presented to our emergency department 
with left-sided weakness. Three months prior to this presen-
tation, the patient developed his first throbbing headache 
which was preceded by an aura of right facial throbbing sen-
sation. He had nausea and photosensitivity during the head-
ache. One day prior to his presentation, the patient reported 
an episode of headache associated with left-sided numbness. 
When he arrived to our emergency department, his symp-
toms had progressed to left hemiparesis. On examination, the 
patient was found to have left hemiparesis and left hemi-
sensory loss to pain and temperature. Initial cranial CT was 
unremarkable. MRI of the brain performed 48 hours after 
onset of symptoms showed an ischemic infarct in the poste-
rior limb of the right internal capsule (images not shown). 
Cerebral magnetic resonance angiography (MRA) was un-
remarkable with no evidence of cerebral angiitis. Evaluation 
for coagulopathy, inborn error of metabolism and DNA 
marker for mitochondrial encephalomyopathy, lactic acido-
sis, and stroke-like episodes was unremarkable. Cerebral 
spinal fluid (CSF) analysis showed no leukocytosis. The 
patient had a first-degree relative who experienced migraine 
without aura, but there was no family history of genetic or 
cerebral vascular disorders. An echocardiogram showed no 
structural abnormality, thrombus, or patent foramen ovale. 
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symptoms improved with a residual mild decreased fluidity 
in left rapid alternating hand movement and left facial weak-
ness. The patient received nimodipine 10 mg intravenously 
every 8 hours for 72 hours (the dose was carefully titrated to 
avoid hypotension). The patient was discharged on aspirin 
81 mg daily. At the follow up visit, the patient reported to 
have infrequent migraine headaches with and without tran-
sient left sided face and arm numbness.  
Case 3 
  A 15 year-old African American non-obese girl presented 
to our clinic with a two-year history of frequent migraine 
headache (once to twice per week). Approximately 6 months 
after her initial migraine onset, the patient experienced an 
aura of left hemi-sensory numbness shortly prior to her 
headache and lasted a few hours after her headache resolved. 
Since then, the majority of her migraine headache episodes 
had been associated with either right or left hemi-sensory 
numbness lasting less than 60 minutes. Her headache was 
pulsatile and associated with photophobia. Physical exami-
nation during one of the headache episodes showed reduced 
sensation to pain and temperature on the left side of her 
body. MRI and MRA of the brain performed during a typical 
headache episode, when the headache had just resolved but 
hemi-sensory loss still persisted, showed no abnormality. 
There was no evidence of cerebral vasculitis. Evaluation for 
coagulopathy and risk factors for stroke were unremarkable. 
The patient reported that she had never smoked and had 
never been on oral contraceptives or used any recreational 
drugs. There was no family history of migraine or stroke. 
The patient’s migraine frequency and duration of headache 
episodes improved with the addition of valproate to her ex-
isting verapamil regimen. Despite having occasional head-
ache with aura, the patient had no neurological deficits dur-
ing multiple clinical evaluations the following 18 months. 
The diagnosis of migraine with aura was made when the 
duration of aura became typical and the evaluation excludes 
other causes of her fully-reversible sensory symptoms. 
Case 4 
  A 20 year-old Hispanic non-obese man was evaluated in 
our clinic for a 5-year history of migraine with aura. There 
was no family history of migraine headache or stroke. He 
denied cigarette smoking and recreational drug use. His 
headaches started when he was 15 years old. The headaches 
were always preceded by a bilateral peripheral visual field 
loss with only a small tunnel of central vision preserved. The 
visual disturbance aura typically began 10-15 minutes prior 
to the headache and resolved once the headache began. The 
patient’s headache did not respond to propranolol. In addi-
tion, the patient reported two prior episodes of headache that 
was preceded by right hemiplegia and resolved within 30 
minutes after headache onset. The patient’s headache was 
triggered by eating greasy and salty food. An MRI of the 
brain performed during the inter-ictal phase 5 years after 
initial onset of migraine was unremarkable. The patient was 
started on verapamil with improvement of headache fre-
quency. Over the period of one year after the initiation of 
verapamil therapy, the patient’s headache became less fre-
quent and there had been no associated focal neurological 
deficits. No abnormal physical exam findings of visual or 
motor deficits were appreciated during multiple subsequent 
clinical visits.  
DISCUSSION 
  Each of the four cases of migraine with aura outlined 
above presented with unique and atypical features that re-
sulted in a diagnostic challenge. The patient in Case 1, who 
previously had no aura associated with her migraine, pre-
sented with migrainous infarct resulting in focal deficit. The 
presence of aura during subsequent headache episodes re-
sulted in reclassification of her condition as having migraine 
with aura. In contrast, the patient in Case 2 was quickly di-
agnosed with migrainous infarct due to the presence of pre-
vious migraine with aura, although the aura was atypical. 
Patients in both cases developed subcortical cerebral 
ischemic infarcts only months after the initial onset of mi-
graine with resultant motor and sensory deficits. The patient 
presented in Case 3 had sensory deficits which lasted greater 
than 60 minutes but less than 7 days with no MRI evidence 
of an ischemic infarct. The long duration of her hemi-
sensory loss, persisting for at least 10 hours after her head-
ache resolved, suggests a prolonged but reversible vaso-
spasm resulting in recurrent transient ischemia. However, 
her headache did not fulfill the International Headache Soci-
ety diagnostic criteria for either migraine with aura or persis-
tent aura without infarct. Finally, case 4 fulfilled the diagno-
sis of sporadic hemiplegic migraine with aura, presenting 
with visual loss or hemiplegia associated with headache. 
Similar to Case 3, there was no clinical or MRI evidence of 
ischemic infarct. 
  Two of the four cases presented had stroke. A full review 
of the history failed to reveal risk factors for stroke in any of 
the patients. In all cases, age, sex, ethnic background or fam-
ily history was not a risk factor in determining a permanent 
infarct. Additionally, none of the patients used hormonal or 
other agents associated with infarct or coagulopathy and 
none of the children smoked cigarettes. Evaluation for mito-
chondrial disorders, cerebral vasculopathy, the syndrome of 
transient headache and neurologic deficits with CSF lym-
phocytosis did not reveal any explanation for the neurologi-
cal deficits in these cases.  
  Two of the four adolescents who suffered from migraine 
and focal neurological deficits had permanent ischemic in-
farcts. Extensive investigation in these two children failed to 
reveal an etiology of the ischemic infarct. Thus, no features 
were available prior to the actual stroke that allowed predic-
tive insight into the future neurological deficits.  
  The exact mechanism underlying migrainous infarct is 
yet to be understood. However, a dysfunction of cerebral 
arteries during migraine attacks and findings of silent infarct-
like brain lesions in migraineurs imply an association be-
tween stroke and migraine. Possible mechanisms leading to 
the infarct include vasospasm and decrease in cerebral blood 
flow, vasculopathy (such as endothelial dysfunction, genetic 
vasculopathies, and polymorphisms in genes regulating en-
dothelial function), platelet hyper-aggregability, and associa-
tions with cardiac abnormalities [6, 23-26]. Previous studies 
utilizing cerebral angiography in patients with neurological 
deficits during a migraine attack demonstrated carotid or 
vertebral artery system vasospasm to a degree that might 
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more, it has been theorized that cerebrovascular dysautono-
mia may occur with transient vasospasms and periods of 
vasodilation [27, 29].
 Linetsky et al.
 prospectively studied six 
patients with stroke who had an ischemic lesion in the same 
vascular distribution as their migraine aura and found that 
stroke occurred during the ictal phase of the migraine [28]. 
In their study, patients underwent a breath-holding test dur-
ing continuous transcranial doppler monitoring. They hy-
pothesized that carbon dioxide accumulation would cause 
vasoconstriction and a resultant increase in velocity in cere-
bral blood vessels. After 25-40 seconds of breath-holding, 
the middle cerebral artery velocities remained unchanged on 
the affected side but increased by 35%-45% on the unaf-
fected side. This supports the idea that during a migraine 
attack, the affected cerebral vessels become maximally di-
lated. Similarly, Rosengarten et al. demonstrated increased 
cerebrovascular reactivity (an increased tone of the vessels) 
in adolescents with migraine without aura during migraine 
attacks as compared to that during headache-free intervals 
[30]. Collectively, these two studies support the theory that 
vascular dysautonomia plays a central role in the pathogene-
sis of cerebral infarcts associated with migraine. 
  There is increasing evidence that cortical spreading de-
pression may be responsible for the aura associated with 
migraine. Cortical spreading depression occurs when a brief 
but intense neuronal and glial depolarization spreads across 
the cerebral cortex followed by prolonged neuronal suppres-
sion [31-33]. Neuroimaging studies [34-36] have revealed 
changes in visual cortex blood flow during migraine aura 
that are consistent with those reported in rats during cortical 
spreading depression [32]. In rats, cortical spreading depres-
sion results in a persistent increase in oxygen consumption 
with impaired neurovascular and neurometabolic coupling 
[37] ultimately leading to glucose depletion [38]. This corti-
cal spreading depression-induced oligemia usually begins in 
the occipital lobes and progresses anteriorly and is thought to 
be responsible for migraine aura [39]. In fact, the consistent 
occurrence of cortical spreading depression together with 
oligemia in the occipital lobes might help explain the pre-
dominance of visual disturbance during migraine-associated 
auras. Additionally, platelet microaggregation (an abnormal-
ity that can be augmented by oral contraceptives, alcohol, 
cigarette smoking or diabetes) was more likely to be associ-
ated with “spreading oligemia” in migraineurs as compared 
to controls [39].
 Thus, it is postulated that cortical spreading 
depression is associated with a vascular dysautonomia 
(vasodilation, hyperemia) and is followed by a period of oli-
gemia [40, 41]. 
  The exact relationship between cortical spreading depres-
sion and ischemic infarct has been the topic of a number of 
excellent reviews [42-44]. It is clear that cortical spreading 
depression together with peri-infarct depolarization follows 
cerebral artery infarct and may be partly responsible for in-
creasing the extent of neuronal damage [45,46]. It is also 
likely that cortical spreading depression will trigger infarct if 
it is sufficiently protracted, leading to compromised tissue 
metabolism [see 43]. Case 1 appears to represent the former 
scenario with the headache occurring hours after the 
ischemic infarct. Case 2 appears to represent the second sce-
nario with the headache and aura clearly proceeding the 
ischemic infarct. 
  The factors that might determine if a focal neurological 
deficit was a reversible aura or permanent infarct have yet to 
be fully evaluated. The International Headache Society 
commented that a decrease in regional cerebral blood flow, 
usually above an ischemic threshold, corresponds with the 
clinical aura seen in migraineurs [1]. We now speculate that 
this threshold might be lower in susceptible individuals. If 
this hypothesis is to be held, a prolonged aura associated 
with vascular dysautonomia might lead to cerebral ischemia 
and infarct. If the presumed diminished regional cerebral 
blood flow for case 2 was below the ischemic threshold, it 
might have resulted in an infarct. Alternatively, if the dimin-
ished regional blood flow for cases 3 and 4 was above the 
threshold, it might allow for reperfusion without permanent 
injury to the corresponding brain tissue. The four cases out-
lined previously demonstrate a range of neurological deficits 
that possibly reflect a spectrum of different degrees of vaso-
spasm. The patient in case 1 sustained a cerebral infarction 
associated with her first migraine with aura that gradually 
improved with the combination of verapamil and valproate. 
In contrast, the patient in case 2 experienced aura without 
focal neurological deficits during his previous migraine at-
tacks but permanent infarct occurred during his current pres-
entation. It is possible that the degree and duration of cere-
bral vasospasm/hypoperfusion are the two variables that may 
predict a wide range of neurological deficits across patients 
with migraine and determine whether focal deficits are re-
versible or permanent. These two variables might help to 
explain the range of neurological deficits observed in our 
patients.  
  Drug therapy has been considered a precipitating factor 
of cerebral infarction in patients with a history of migraine. 
Although recent studies dispute triptans as causative agents 
of migraine stroke [47], the use of ergotamines and suma-
triptan have been shown to cause constriction of cerebral 
vessels and precipitate ischemia [12,48]. Dash et al. de-
scribed a case of cerebral infarction with angiographic evi-
dence of vasospasm in a patient on sumatriptan for chronic 
migraine headache [49].
 Angiographic follow up revealed a 
significant improvement in cerebral vasospasms seven days 
after discontinuing the sumatriptan. Likewise, the use of 
propranolol as a prophylactic agent for migraine has also 
been suggested as a contributing factor for hypotension and 
cerebral hypoperfusion leading to cerebral infarction [50, 
51]. None of our patients used an ergotamine or a beta 
blocker, thus ruling out these drugs as causing the auras and 
neurological deficits. 
  The cases outlined herein demonstrate that no specific 
risk factor or reliable clinical marker could be used to iden-
tify children at risk for irreversible cerebral ischemia. In-
deed, migraine with aura was present in all four cases, and 
two showed permanent infarct, an observation that provides 
support linking migraine with aura to stroke in children. We 
acknowledge that this case series does not have the rigor of a 
large cohort prospective study on the association of migraine 
with aura and stroke in children. To date, this association has 
not been addressed in children, though it has been estab-
lished in adults.  
  In summary, we conclude that there may be a connection 
of migraine with aura and stroke in children and adolescents. 
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stroke, our case series showed benefit of the prophylactic 
treatment in reducing frequency of migraine attacks thereby 
theoretically reducing the chance of stroke, especially since 
high frequency migraine attack was associated with ischemic 
stroke in adults [13]. Until a reliable clinical biomarker can 
be identified and given that prophylactic therapy is relatively 
safe but seriously underutilized, we advocate aggressive 
treatment using prophylactic agents that can prevent vaso-
spasm in children who suffer from migraine with aura, espe-
cially for prolonged auras. We also caution against the use of 
any agent including triptans that can lead to vasospasm in 
children with migraine [52].  
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